My Top AI Healthcare Stock to Buy and Hold for 20 Years

Core Insights - Artificial intelligence (AI) is transforming industries and creating investment opportunities, particularly in healthcare [1] - Eli Lilly (NYSE: LLY) is positioned as a leading AI healthcare stock with significant initiatives [2] Group 1: AI Initiatives by Eli Lilly - Eli Lilly is launching TuneLab, an AI drug discovery platform, available for free to smaller biotech companies to enhance drug discovery [5] - The company is partnering with Nvidia to develop the most powerful AI supercomputer in the pharmaceutical industry [6] - Eli Lilly is establishing an AI drug discovery lab in the San Francisco Bay Area in collaboration with Nvidia to expedite drug discovery processes [6] Group 2: Long-term Growth Potential - Eli Lilly's AI initiatives are expected to reduce R&D costs and research time, benefiting the company and its shareholders [7] - The company is poised to capitalize on the growing weight-loss market, maintaining leadership even after losing patent exclusivity on some products [8] - Eli Lilly has strengthened its product pipeline through internal development and acquisitions, with promising offerings in neuroscience, immunology, and oncology [8]